could be very bullish today
Morning Star and Insider Monkey 6/12/13 To Verify Paste Info Into Google:
With these "truths" under our belt, let's take a look at the key action surrounding Celldex Therapeutics, Inc. (NASDAQ:CLDX).
How are hedge funds trading Celldex Therapeutics, Inc. (NASDAQ:CLDX)?
Heading into Q2, a total of 16 of the hedge funds we track were long in this stock, a change of 33% from one quarter earlier. With hedgies' capital changing hands, there exists a few key hedge fund managers who were increasing their holdings significantly.
there's alot of news here's one:
ly On The Wall 6/12/13
June 12, 2013
CLDX Celldex price target raised to $19 from $14 at Brean Capital Brean Capital raised its price target on Celldex due to its strong clinical data and robust pipeline. Shares are Buy rated.
yahoo charts 6/12/13
your a short pretending to be long,, think were stupid. Adam F. doesn't go after ACAD or Great Biotechs, He goes After CLSN and MNKD. The FDA is 100% behind ACAD and Baker Bros Buying over 22% .
$26 Before U Know It.